## TSLA: Tesla, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 5.1% in mid entry zone (3.0-6.0%), top quartile (89th pct) cross-sectional ranking. Short-term MRS_5 (3.3%) confirms momentum alignment. Strong momentum (+3.0% 5-day acceleration). Outperforming sector by 5.0%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($418.45)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 2, Bearish: 4)

**1. Tesla Stock Jumps on Robotics Push and China Rebound as UK Sales Slump: TSLA Outlook for 2025–2030 (December 4, 2025)**
- Source: ts2.tech | 20251204T130859 | Neutral | Relevance: 100%
- Tesla's shares surged on December 4, 2025, driven by a White House robotics push, a significant US clean-energy grant, and a sharp rebound in China sales. This positive momentum contrasts with struggling sales in Europe, particularly a 19% year-on-year drop in the UK, and ongoing quality concerns with the Cybertruck. Analysts are divided, with some seeing short-term overvaluation but anticipating long-term growth fueled by Tesla's AI and robotics ventures.

**2. Michael Burry Says Tesla Is ‘Ridiculously Overvalued.’ Should You Ditch TSLA Stock Here?**
- Source: Barchart.com | 20251203T201000 | Bearish | Relevance: 100%
- The article discusses Michael Burry's assertion that Tesla (TSLA) is "ridiculously overvalued" due to contracting EV deliveries and significant lags in the robotaxi race. The author agrees with Burry, citing the unproven value of Tesla's robots and past failures of Elon Musk's grandiose plans. It recommends investors sell TSLA stock given the competition and the company's valuation metrics.

**3. Gains for Tesla offset drop in other 'Magnificent Seven' stocks**
- Source: MarketWatch | 20251203T182340 | Somewhat-Bullish | Relevance: 100%
- Tesla Inc. shares saw a significant climb, helping to maintain a popular exchange-traded fund tracking the "Magnificent Seven" megacap tech stocks in positive territory. This gain for Tesla offset declines experienced by several other major tech companies including Microsoft, Amazon, Nvidia, Meta Platforms, and Apple. Meanwhile, Google's parent company, Alphabet Inc., also recorded a modest increase in its stock value.

**4. Tesla just posted rare growth in China. Here’s what sparked the sales momentum.**
- Source: MarketWatch | 20251202T161600 | Bullish | Relevance: 100%
- Tesla experienced a rare surge in sales growth in China during November, making it the second-best performance in 2025 by units sold. This sales momentum was driven by new trims of its best-selling models, resulting in 86,700 China-made EVs sold. This growth is significant as it marks only the third month this year Tesla has seen sales growth in the major EV market, despite FactSet consensus indicating a projected global delivery decline for 2025 compared to previous years.

**5. Tesla Stock Today (TSLA): Michael Burry’s New Short, China Sales Jump and 2026 Robotaxi Bets – December 2, 2025**
- Source: ts2.tech | 20251202T135116 | Neutral | Relevance: 100%
- This article examines Tesla (TSLA) stock as of December 2, 2025, detailing Michael Burry's renewed short position and criticism of its valuation, alongside strong China sales and bullish analyst projections for robotaxis. It highlights Tesla's status as a polarizing stock, facing slow auto growth and margin pressure but holding significant long-term potential in AI and autonomy. The piece dissects the bear and bull cases, regional performance, and key debates driving TSLA's volatile valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-25 | Mizuho | $475 | $485 | -2% |
| 2025-11-17 | Stifel | $508 | $483 | +5% |
| 2025-11-07 | Wedbush | $600 | $600 | 0% |
| 2025-11-05 | Wedbush | $600 | $600 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-25 | Mizuho | main | Outperform |
| 2025-11-17 | Stifel | main | Buy |
| 2025-11-07 | Wedbush | reit | Outperform |
| 2025-11-05 | Wedbush | reit | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($141568.60M) |
| Sells | 3 ($1.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 26.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+0.4%)
- Blackrock Inc.: 6.2% (+0.4%)
- State Street Corpora: 3.4% (+0.3%)
- JPMORGAN CHASE & CO: 2.7% (+94.0%)
- Geode Capital Manage: 2.0% (+0.9%)

### Key Risks

1. High beta (1.88) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Valuation stretched: PEG 9.5x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +3.0% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 9.49 signals overvaluation risk, limited margin of safety. Forward P/E 205.8x stretched relative to 35% growth. Balance sheet: strong liquidity (2.1x), $4.0B free cash flow. Insider buying signal ($141568.6M), management confidence. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $1580.4B |
| Beta | 1.88 |
| 52W Range | $214.25 - $498.83 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 9.49 |
| Forward P/E | 205.8 |
| Current P/E | 277.5 |
| YoY Growth | 34.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from 2.2% to 5.1% (+3.0% in 5 days), confirming momentum buildup. Currently in upper STRENGTH zone (3.0-6.0%), cross-sectional ranking at 89th percentile. MRS_5 at 3.3% confirms short-term momentum alignment. Outperforming sector by 5.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.56), confirming momentum. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 5.14% (CS: 90) | Strong |
| RSI_14 | 60.9 | Neutral |
| MACD Histogram | 4.56 | Bullish |
| vs SMA20 | 1.076x | Above |
| vs SMA50 | 1.046x | Above |
| vs SMA200 | 1.329x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $454.53
- **Stop Loss:** $418.45 (7.9% risk)
- **Target:** $508.65 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 27
- **Position Value:** $12,272.31
- **Portfolio %:** 12.27%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-28 (Est: $0.45)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.56 | $0.50 | -10.5% |
| 2025Q2 | $0.40 | $0.40 | -1.0% |
| 2025Q1 | $0.41 | $0.27 | -34.9% |
| 2024Q4 | $0.77 | $0.73 | -4.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*